Working… Menu

Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04343651
Recruitment Status : Active, not recruiting
First Posted : April 13, 2020
Last Update Posted : August 20, 2020
Information provided by (Responsible Party):
CytoDyn, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 21, 2020
Estimated Study Completion Date : August 31, 2020